TaiwanJ Pharmaceuticals Co Ltd

NEW
ROCO:6549 (Taiwan)  
NT$ 7.13 -0.060 (-0.83%) Jul 3
At Loss
P/B:
8.06
Market Cap:
NT$ 571.27M ($ 17.89M)
Enterprise V:
NT$ 505.23M ($ 15.82M)
Volume:
244.89K
Avg Vol (2M):
160.73K
Trade In:
Volume:
244.89K
At Loss
Avg Vol (2M):
160.73K

Business Description

Description
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.
Name Current Vs Industry Vs History
Cash-To-Debt
37.93
Equity-to-Asset
0.92
Debt-to-Equity
0.03
Debt-to-EBITDA
-0.08
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
36.26
9-Day RSI
38.25
14-Day RSI
40.24
3-1 Month Momentum %
-1.68
6-1 Month Momentum %
-1.68
12-1 Month Momentum %
-4.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
13.81
Quick Ratio
13.81
Cash Ratio
12.76

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-2
Shareholder Yield %
-0.23

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-29.38
ROA %
-27.44
ROIC %
-305.98
3-Year ROIIC %
-766.64
ROC (Joel Greenblatt) %
-719.45
ROCE %
-29.04

Financials

ROCO:6549's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

TaiwanJ Pharmaceuticals Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$)
EPS (TTM) (NT$) -0.3
Beta 0.0175
3-Year Sharpe Ratio -1.59
3-Year Sortino Ratio -1.62
Volatility % 14.7
14-Day RSI 40.24
14-Day ATR (NT$) 0.327471
20-Day SMA (NT$) 7.3965
12-1 Month Momentum % -4.28
52-Week Range (NT$) 6.91 - 10.6
Shares Outstanding (Mil) 80.12

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TaiwanJ Pharmaceuticals Co Ltd Filings

Filing Date Document Date Form
No Filing Data

TaiwanJ Pharmaceuticals Co Ltd Stock Events

Financials Calendars
Event Date Price (NT$)
No Event Data

TaiwanJ Pharmaceuticals Co Ltd Frequently Asked Questions

What is TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549)'s stock price today?
The current price of ROCO:6549 is NT$7.13. The 52 week high of ROCO:6549 is NT$10.60 and 52 week low is NT$6.91.
When is next earnings date of TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549)?
The next earnings date of TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549) is .
Does TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549) pay dividends? If so, how much?
TaiwanJ Pharmaceuticals Co Ltd(ROCO:6549) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on TaiwanJ Pharmaceuticals Co Ltd

No articles.